VRC 612 Part C Study Team

Independent

SCHOLARLY PAPERS

1

DOWNLOADS

106

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Optimization of the CIS43LS Malarial Monoclonal Antibody and Protection Against Malaria

Number of pages: 26 Posted: 07 Oct 2022
University of Maryland - Center for Vaccine Development and Global Health, University of Maryland - Center for Vaccine Development and Global Health, University of Maryland - Center for Vaccine Development and Global Health, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Government of the United States of America - Biostatistics Research Branch, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, University of Maryland - Center for Vaccine Development and Global Health, University of Maryland - Center for Vaccine Development and Global Health, University of Maryland - Center for Vaccine Development and Global Health, University of Maryland - Center for Vaccine Development and Global Health, Walter Reed Army Institute of Research, Walter Reed Army Institute of Research, Peking University, School of Public Health, Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, University of California, San Diego (UCSD), Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Peking University, School of Public Health, Vaccine Research Center, Government of the United States of America - Vaccine Research Center and Independent
Downloads 106 (555,542)

Abstract:

Loading...

Malaria, monoclonal antibody, Plasmodium falciparum, Circumsporozoite Protein, Subcutaneous, CIS43LS